Megalencephaly-Capillary Malformation-Polymicrogyria syndrome (MCAP)

Qu'est-ce que Megalencephaly-Capillary Malformation-Polymicrogyria syndrome (MCAP)?

Mégalencéphalie-Malformation Capillaire syndrome est un trouble de malformation multiple. Sa gravité varie selon les individus.

D'abord identifié dans 1997 comme un trouble distinct, il n'y a eu que 140 cas signalés depuis lors, mais il peut y avoir un sous-diagnostic contribuant à ce chiffre.

Cette maladie du développement rare implique principalement une prolifération tissulaire dans différentes parties du corps. Un gros cerveau (mégalocéphalie) est l'une des principales caractéristiques de la syndrome.

Syndrome Synonymes :
M-CM Macrocéphalie - malformation capillaire Macrocéphalie-malformation capillaire ; Mcm Macrocéphalie-cutanée Marmorata Telangiectatica Congenita ; Mcmtc MCAP MCTC Mégalencéphalie - malformation capillaire Mégalencéphalie-malformation capillaire Syndrome Mégalencéphalie cutanée Marmorata Telangiectatica Congenita Surcroissance - polysyndactylie - hémangiomes Surcroissance-polysyndactylie-hémangiomes

Quelles sont les causes des changements génétiques Megalencephaly-Capillary Malformation-Polymicrogyria syndrome (MCAP)?

Mutations somatiques du gène PIK3CA. On ne pense pas que ce soit une condition héréditaire.

L'hérédité de la mosaïque se produit très tôt dans le développement d'un fœtus. Il s'agit essentiellement d'une erreur de division cellulaire. Le corps humain est composé de 46 chromosomes, répartis en 23 paires. Le mosaïcisme se produit lorsqu'un individu a des cellules dans son corps avec plus ou moins de chromosomes que les 46 habituels. Cela peut déclencher des problèmes qui affectent différents systèmes et parties du corps.

Quels sont les principaux symptômes de Megalencephaly-Capillary Malformation-Polymicrogyria syndrome (MCAP)?

Le principal symptômes de la syndrome comprennent la prolifération cérébrale (mégalencéphalie) une grosse tête.

Les malformations capillaires ou les lésions cutanées du visage, du tronc et des membres sont des symptôme. Un front proéminent, des doigts et des orteils supplémentaires, ainsi qu'une peau et des articulations lâches sont également symptômes de la syndrome. Tout comme l'asymétrie corporelle.

D'autres problèmes de santé associés à la syndrome comprennent un faible tonus musculaire, des convulsions et des malformations cardiaques. Symptômes peut varier considérablement d'un individu à l'autre.

Traits/caractéristiques cliniques possibles :
Cavum septum pellucidum, Ischémie cérébrale, Croissance asymétrique, Malformation d'Arnold-Chiari, Aplasie/hypoplasie du cervelet, Malformation artérioveineuse, Bossage frontal, Sporadique, Mutation somatique, Communication interventriculaire, Angiomatose viscérale, Macrocéphalie, Télangiectasie neuronale, Anomalie de la peau Migration, Néphroblastome, Microphtalmie, Mégalencéphalie, Méningiome, Arythmie, Leucémie, Hypotonie musculaire, Macrocéphalie progressive, Déficience intellectuelle, Hypermobilité articulaire, Laxité articulaire, Bouche large, Atrophie optique, Excroissance, Syndactylie des orteils, Saisie, Syndactylie, Grand lobe de l'oreille, Polydactylie polydactylie, Polydactylie de la main, Polymicrogyrie, Épicanthus, il enfoncé, Ventriculomégalie, Asymétrie faciale, Syndactylie des doigts, Philtrum lisse, Cutis marmorata, Fissures palpébrales inclinées, Malformation du cœur et des gros vaisseaux, Pont nasal déprimé, Joues pleines, Hypertélorisme, Hypermélanose , Hydrocéphalie, Front haut, Front large, Hernie, Cogn déficience intellectuelle, mondiale

Comment quelqu'un se fait-il tester pour Megalencephaly-Capillary Malformation-Polymicrogyria syndrome (MCAP)?

Le test initial pour la mégalencéphalie-malformation capillaire-polymicrogyrie peut commencer par un dépistage par analyse faciale, à travers le FDNA Telehealth plate-forme de télégénétique, qui peut identifier les marqueurs clés du syndrome et souligner le besoin de tests supplémentaires. Une consultation avec un conseiller en génétique puis un généticien suivra. 

Sur la base de cette consultation clinique avec un généticien, les différentes options de tests génétiques seront partagées et le consentement sera recherché pour d'autres tests.

Informations médicales sur la Mégalencéphalie-Malformation Capillaire-Polymicrogyrie Syndrome

Barnicoat et al., (1996) reported two infants with a similar syndrome of overgrowth, haemangiomas, and polydactyly associated with syndactyly. In one female infant birth weight and head circumference were above the 97th centile whereas length was between the 50th and 90th centile. Hypoglycaemia developed on day two but was easy to control and there was no evidence of hyperinsulinaemia. Hypoglycaemia and thrombocytopenia needing treatment were problems in the first few days of life. The facial features were coarse with a relatively large head. The neck was short with redundant skin folds. The nasal bridge was flat. There was a large cavernous haemangioma on the right shoulder. There was syndactyly between fingers 3-4 on both hands and post-axial polydactyly of both feet. Radiographs showed severe demineralisation of the skeleton with Wormian bones in the skull. The long bones were slender. CT brain scan showed mild periventricular leukomalacia and a mild communicating hydrocephalus initially, but intracranial pressure increased and a shunt was needed by three months. The second infant had somewhat similar features. There was no generalised macrosomia but the hands were disproportionately large. The facial features were similar to the first case. There were large capilliary haemangiomata over the palmar and dorsal aspects of both hands and on the back, as well as on both feet and legs. There was a cavernous haemangioma on the left axilla and also one on the left cheek and upper lip displacing the nose to the right. Post-axial polydactyly of the left hand with bilateral 3-4 syndactyly of the fingers with fused nails on one side were noted. There was 2-3 and 4-5 syndactyly of both feet. NMR scanning of the brain showed hydrocephalus and a venous malformation with massive dilation of the sagittal, straight and sigmoid sinuses with thrombosis.
Toriello et al., (1996), Clayton-Smith et al., (1997) and Moore et al., (1997) reported a group of children with a distinctive overgrowth syndrome. This is characterised by macrocephaly, limb asymmetry, and vascular stains. Birth weight is increased. There were cutis marmorata and a characteristic haemangioma of the philtrum of the upper lip. These cutaneous features may fade with age. Carcao et al., (1998) reported a case where MRI scans showed protrusion of the cerebellar tonsils through the foramen magnum, a lumbar syrinx and ""hydrops of the optic nerves"".
Franceschini et al., (2000) reported two convincing cases without cutis marmorata. The patient reported by Hallett et al., (1995) seems to have features of the condition although there was also acanthosis nigricans and gingival fibromatosis. Yano and Watanabe (2001) reported three cases of poor clinical outcomes. In two cases there were intractable cardiac arrhythmias and sudden death. Robertson et al., (2000) reported five further cases and provide a good review. Lapunzina et al., (2004) have done the same. Schwartz et al., (2002) reported a male with some features of the condition (although not entirely convincing) who had a retinoblastoma. It seems likely that the case reported by Megarbane et al., (2003) with polydactyly and intestinal lymphangiectasia falls into this group. A case reported by Stoll (2003) had a t(2;17)(p11;p13) translocation.
Garavelli et al., (2005) looked at the MRI findings of 10 cases and found abnormalities in all (megalencephaly, asymmetry, increased white matter signals). Giuliano et al., (2004) reported seven cases and stress the neurological sequelae (all were delayed, five cases had cerebral asymmetry with hemimegalencephaly in three, hydrocephalus in three and an Arnold-Chiari type I in one).
The neurological features of 17 patients were discussed by Conway et al., (2007). White matter irregularities (increased signal on T2-weighted images) were found in the majority and a distinctive feature was cerebellar tonsilar herniation and progressive crowding of the posterior fossa. This, postulated the authors, suggested a dynamic process, possibly initiated by a rapidly growing cerebellum, congestion of venous drainage and an increase in pressure, that led, in some of their cases, to tonsillar herniation. They also found evidence of an abnormal cortical morphogenesis.
A long-term follow-up of a case reported by Canham and Holder (2008) showed that growth and head circumference ended up just within the normal range, that the vascular skin lesions faded with time. Only the varicosities (in this case mild) remained.
Note however that of the 12 cases reported by Wright et al., (2009), all showed a reticulated or confluent port-wine stain (not cutis marmorata) and seven had centrofacial capillary malformations. There is macrocephaly with ventricular dilatation. Syndactyly between toes 2 and 3 is common and there may be limb asymmetry. Some cases have 3/4 syndactyly of the fingers and occasionally post-axial polydactyly. Congenital heart defects have occasionally occurred (Dinleyici et al., 2005, Gonzalez et al., 2009). There may also be joint laxity and hyperelastic skin. Developmental delay is common. MRI scans may show evidence of delayed myelination. Hydrocephalus usually develops. Apnoe due to cranio-cervical cord compression has also been reported (Franklin et al., 2009). See under Hemihypertrophy-hemimegalencephaly-polydactyly for a condition with similar features. Proteus syndrome has to be considered. Note the three cases reported by Gonzalez et al., (2009) who state that unlike Proteus there may be checker-board pattern to the hypertrophy ie., face, and then the leg opposite to the trunk). They also state that unlike Proteus the hypertrophy occurs irrespective of the vascular stain.
The clinical features and diagnostic criteria are well reviewed by Martinez-Glez et al., (2010).
Polymicrogyria and a thickened corpus callosum are also features (Mirzaa et al., 2012).
The case reported by Papetti et al., (2012) had hemimegalencephaly, polymicrogyria and cerebellar tonsillar herniation.
Discordant monozygotic twins were reported by Lederer et al., (2012). Note the excellent paper by Reviere et al., (2012) who looked at three families with either MPPH or MCAP and thereafter further cases, They found two mutations in AKT3, one in PIK3R2 in 11 unrelated families with MPPH and 15, mostly postzygotic mutations in PIK3CA in 23 individuals with MCAP and one with MPPH. It could be that PTPN11 is also involved (Docker et al., 2015).
McDermott et al., (2016) detected the presence of PIK3CA mutation in hair and in the secondary tooth of the affected individual. Dental crowding as the clinical manifestation of the PIK3CA mutation within the dental tissue has been suggested by Canham and Holder (2008).
Mirzaa et al., (2016) identified PIK3CA mutations in 60 individuals in a cohort of 181 individuals with brain and body overgrowth. Sixteen of 29 PIK3CA mutations were novel. The phenotypes were not simply related to the level and distribution of PIK3CA mutations, but also to the class of mutation. The clinical presentation was as follows: (1) severe focal overgrowth due to low-level but highly activating hotspot mutations, (2) predominantly brain overgrowth and less severe somatic overgrowth due to less-activating mutations, (3) intermediate phenotypes (capillary malformations with overgrowth) with intermediately activating mutations. Levels of mosaicism were on average lower in peripheral blood lymphocytes than saliva, and lower in saliva than in skin fibroblasts. In ten patients germline or apparently germline PIK3CA mutations were identified.
Yeung et al., (2017) described seven molecularly confirmed patients with PIK3CA-Related Overgrowth Spectrum. Clinical presentations included congenital lipomatous overgrowth, vascular malformations, epidermal nevi, scoliosis and other skeletal abnormalities, Klippel–Trenaunay syndrome, lymphatic malformations. Two individuals showed atypical phenotypes that cannot be classified into existing disease categories. The age of patients ranged from three to 18 years. Central nervous system was unaffected in all the patients.
Takagi et al., (2017) described a boy with megalencephaly and a de novo heterozygous missense mutation in the AKT3 gene. Clinical characteristics included hypotonia, developmental delay, frontal bossing, flattened nasal bridge and hyperlaxity. Novel features were transient hypoglycemia, and growth hormone deficiency.
Alcantara et al., (2017) described 14 additional patients with AKT3 mutations. Patients with highly asymmetric cortical dysplasia usually had the common p.E17K mutation; patients with constitutional AKT3 mutations showed more variable phenotypes (bilateral cortical malformations, polymicrogyria, periventricular nodular heterotopia, diffuse megalencephaly without cortical dysplasia).
Steiner et al., (2018) described six patients with PIK3CA gene mutation-related segmental overgrowth syndromes. All patients had a history of previous surgery and four of them developed abnormal scarring in tissue affected by overgrowth.
A male patient polymicrogyria in association with hypoglycemia was described by Stutterd et al. (2018). Ventriculomegaly and macrocephaly were noted prenatally. At birth, he showed overgrowth, relative macrocephaly with frontal bossing, coarse facies, broad and upturned nasal tip, full upper lip, low-set ears with squared helix, capillary malformations, redundant skin on hands and feet, and mild lateral deviation of fingers. Brain MRI showed megalencephaly and severe hydrocephalus that required ventriculoperitoneal shunt. Asymptomatic preprandial hypoglycemia, and episodes of atrial ectopic tachycardia were also documented.

* This information is courtesy of the L M D.
If you find a mistake or would like to contribute additional information, please email us at: [email protected]

Soyez plus rapide et plus précis Diagnóstico Genético!

Plus de 250,000 patients analysés avec succès!
N'attendez pas des années pour un diagnostic. Agissez maintenant et gagnez un temps précieux.

Commencer ici!

"Notre chemin vers un diagnostic de maladie rare a été un voyage de 5 ans que je ne peux décrire que comme une tentative de faire un road trip sans carte. Nous ne connaissions pas notre point de départ. Nous ne connaissions pas notre destination. Maintenant nous avons de l'espoir. "

Image

Paula et Bobby
Parents de Lillie

Qu'est-ce que la FDNA Telehealth?

FDNA Telehealth est une entreprise de santé numérique de premier plan qui offre un accès plus rapide à une Analyse Génétique précise.

Dotée d'une technologie hospitalière recommandée par les plus grands généticiens, notre plateforme unique met les patients en contact avec des Experts En Génétique pour répondre à leurs questions les plus urgentes et clarifier toute préoccupation qu'ils pourraient avoir concernant leurs Symptômes.

Avantages de la FDNA Telehealth

Icône FDNA

Credibility

Notre plateforme est actuellement utilisée par plus de 70% des généticiens et a été utilisée pour diagnostiquer plus de 250,000 patients dans le monde.

Icône FDNA

Accessibilité

FDNA Telehealth fournit une analyse faciale et un dépistage en quelques minutes, suivi d'un accès rapide aux conseillers en génétique et aux généticiens.

Icône FDNA

Facilité d'utilisation

Notre processus transparent commence par un diagnostic initial en ligne par un conseiller en génétique et s'ensuit par des consultations avec des généticiens et des tests génétiques.

Icône FDNA

Précision et précision

Capacités et technologies avancées d'intelligence artificielle (IA) avec un taux de précision de 90% pour une meilleure précision analyse génétique.

Icône FDNA

La valeur pour
De l'argent

Accès plus rapide aux conseillers en génétique, aux généticiens, aux tests génétiques et au diagnostic. En moins de 24 heures si nécessaire. Économisez du temps et de l'argent.

Icône FDNA

Confidentialité et sécurité

Nous garantissons la meilleure protection de toutes les images et informations des patients. Vos données sont toujours sûres, sécurisées et cryptées.

La FDNA Telehealth peut vous rapprocher d'un diagnostic.
Planifiez une réunion de conseil ginitique en ligne dans les 72 heures!

EspañolDeutschPortuguêsFrançaisEnglish